Status:
NOT_YET_RECRUITING
Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Parkinson's Disease (PD)
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate an automated deep brain stimulation (DBS) algorithm developed by Boston Scientific called Illumina 3D for motor symptoms in Parkinson's disease (PD). The...
Eligibility Criteria
Inclusion
- Diagnosis of Parkinson's disease (PD)
- Newly implanted or soon to be implanted with deep brain stimulation (Boston Scientific device)
- Willingness to withdraw from clinical medication regimen when necessary for research visits
Exclusion
- Dementia
- Unable or unwilling to come OFF DBS for a short period of time
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07215481
Start Date
December 1 2025
End Date
October 1 2026
Last Update
October 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Neuroscience Health Clinic
Stanford, California, United States, 94305